Healthcare ECONOMIST

JUNE 13, 2022

Despite these positive impacts, a number of political commentators have accused pharmaceutical companies of profiteering. Some analysts predicted that life science companies would make $100 billion in COVID-19 sales and $40 billion in post-tax profits. A study by Ahuja et al. trillion in social value.

Life Sciences 105

Life Sciences Pharmaceuticals Accountability Prevention 105

Healthcare ECONOMIST

AUGUST 29, 2021

It stands to reason that policies that aim to reduce drug prices or squeeze life science companies profits are likely to decrease incentives to finance the research and development needed to bring a drug to market. The figure below show this impact graphically, accounting for uncertainty in some of the underlying parameters.

Life Sciences 94

Life Sciences Pharmaceuticals Medicare Accountability 94

HIT Consultant

JUNE 18, 2023

They use their combination of experience in clinical, procedural and operational expertise to support the C-Suite directly and drive growth in industry verticals such as national population health initiatives, insurance and life sciences partnerships.

Life Sciences 98

Life Sciences Pharmaceuticals Healthcare Innovation Population Health 98

HIT Consultant

NOVEMBER 18, 2021

Benchling , a San Francisco, CA-based life and sciences R&D cloud platform raises $100M in Series F funding at a $6B valuation, co-led by new investor Franklin Templeton and existing investor Altimeter Capital , and joined by new investors Tiger Global and Lone Pine Capital , as well as existing investors.

Biotechnology 97

Biotechnology Life Sciences Pharmaceuticals Accountability 97

HIT Consultant

NOVEMBER 25, 2024

Sujay Jadhav, CEO of Verana Health While most technology- and innovation-oriented industries have followed the general principles of Moore’s Law , which holds that computing power would double yearly, while costs were cut in half, the life sciences industry appears to be spending more money developing fewer drugs.

Life Sciences 98

Life Sciences Pharmaceuticals Integration Regulations 98

GoMoHealth

FEBRUARY 9, 2022

The GoMo Health model leverages sponsorship of healthcare services by hospitals, health systems, plans, pharma and other life sciences providers, extending the reach of care to all who need it. He graduated Rutgers College with degrees in business, accounting and art history. Larry also acquired and managed Nancy H.

Life Sciences 87

Life Sciences Healthcare Accountability Pharmaceuticals 87

HIT Consultant

SEPTEMBER 12, 2024

Ferdinand Hamada, Managing Director and Pharma Life Sciences Industry Lead Partner at MorganFranklin Consulting The role of the Chief Information Security Officer (CISO) has evolved far beyond traditional cybersecurity responsibilities, especially in healthcare organizations.

Life Sciences 98

Life Sciences Healthcare Pharmaceuticals Patient Safety 98

HIT Consultant

JULY 25, 2022

Lauren Ohlsson, Lead of Industry Solutions, Pharmaceutical and Healthcare, at VDX.tv. Consumers continue to cut ties with traditional TV and cable services, prompting industries like the prescription pharmaceutical industry to evolve their marketing mix to accommodate emerging media. . About Lauren Ohlsson.

Pharmaceuticals 98

Pharmaceuticals Accountability Regulations Integration 98

Twistle

OCTOBER 26, 2021

This September, life sciences companies and solution providers came together at Digital Pharma East to share marketing strategies and best practices across the industry. Partnerships between life sciences companies and digital health solution providers are increasing. Below are 3 key takeaways from the event.

Life Sciences 52

Life Sciences Pharmaceuticals Patient Experience Accountability 52

HIT Consultant

APRIL 15, 2024

In fact, in 2018, 80% of all biopharma pipeline projects in JAPAC were EBPs, accounting for 75% of the total clinical trial volume in the region. They are also in communication with the sponsor, who is the MAH of the active pharmaceutical ingredient. In comparison to Japan, China has fewer distinctions.

Pharmaceuticals 96

Pharmaceuticals Patient Safety Accountability Integration 96

Health Populi

APRIL 24, 2019

Pharmaceuticals garner the lowest score at 57, compared with biotech and life sciences at 64. What might account for this drop in trust for healthcare providers? It’s important to note differences in trust across the five healthcare industry segments — and there are big differences.

Healthcare 83

Healthcare Life Sciences Hospitals Pharmaceuticals 83

HIT Consultant

JANUARY 28, 2022

and previously led the RNAi Lead Development group at Alnylam Pharmaceuticals, Inc. Clint started his legal career at Morrison & Foerster and has led legal and operations teams at public and private life science companies. Senda Biosciences, Inc., as Chief Scientific Officer.

Biotechnology 98

Biotechnology Life Sciences Private Practices Healthcare Analytics 98

HIT Consultant

MAY 22, 2023

Though there is a vast level of chemical space to foster the development of drug molecules, a lack of advanced technologies can limit the traditional drug development process, making it time consuming and expensive for pharmaceutical and biotech companies to pursue. What are some of the varying systematic approaches to repurposing?

Pharmaceuticals 96

Pharmaceuticals Accountability Integration Life Sciences 96

HIT Consultant

NOVEMBER 2, 2022

The European Union (EU) has announced guidance on the Identification of Medicinal Product (IDMP) — and pharmaceutical companies around the world should take notice. It’s imperative that companies begin evaluating what changes need to be implemented, and the sooner pharmaceutical companies act, the better. This is no small feat.

Pharmaceuticals 52

Pharmaceuticals Life Sciences Integration Regulations 52

HIT Consultant

JANUARY 19, 2024

8 digital health and life sciences executives share their hot takes and insights from the recent annual JPM Healthcare Conference 2024 Virgil Bretz, co-founder and CEO of MacroHealth “The annual JP Morgan Healthcare Conference is still one of the most efficient ways to meet with capital partners.

Pharmaceuticals 52

Pharmaceuticals Healthcare Life Sciences Integration 52

Lexis Nexis

JULY 24, 2022

Life sciences, pharmaceutical, and medical device companies can all use real-world data to their benefit. Did you know that social factors account for more than 33% of total deaths annually in the U.S.? Now, images may be included in patient datasets.

Life Sciences 52

Life Sciences Pharmaceuticals Accountability Healthcare 52

HIT Consultant

AUGUST 16, 2023

This technology enables pharmaceutical and biotech customers to consider decentralized and hybrid clinical trial strategies in study protocols that would have otherwise been limited to on-site evaluations.

Pharmaceuticals 52

Pharmaceuticals Accountability Integration Life Sciences 52

Healthcare Leadership Council

MAY 25, 2023

Erin Geygan, senior privacy counsel at Johnson & Johnson, explained that the organization is comprised of three segments – pharmaceutical, medtech and consumer health, which have invested $14.6 billion in research and development.

Healthcare Innovation 40

Healthcare Innovation Healthcare Life Sciences Rehabilitation 40

HIT Consultant

OCTOBER 5, 2022

For pharmaceutical manufacturing firms, the amount of documentation required around state price transparency regulations continues to expand. While companies currently provide the mandated data to states, current requirements don’t account for the complexities that would help states to fully understand drug pricing. Kyle Forcier, Sr.

Regulations 52

Regulations Life Sciences Pharmaceuticals Medicaid 52

HIT Consultant

JUNE 18, 2024

What You Should Know: – Mika Health , a leading developer of digital therapeutics for cancer patients, announced a collaborative initiative called “UNITE” alongside pharmaceutical giants AstraZeneca and Daiichi Sankyo. million new cases were diagnosed, accounting for one in four new cancer cases.

Pharmaceuticals 52

Pharmaceuticals Regulations Accountability Life Sciences 52

Health Advances

JUNE 24, 2022

Despite this growth, mRNA vaccine pipeline assets are still dominated by first mover and early innovators Moderna, CureVac, and BioNTech, who account for more than 50% of all advanced mRNA vaccine pipeline assets. Figure 1: Development of mRNA Vaccine Pipeline by Stage and Year, and Pharmaceutical Companies with Advanced Pipeline.

Pharmaceuticals 52

Pharmaceuticals Prevention Accountability Life Sciences 52

Health Populi

MAY 4, 2023

Women thus accounted for one-third of ADHD prescriptions as of December 2022. Health Populi’s Hot Points: Life expectancy in the U.S. There is another data point in the study on women’s health and prescriptions — for ADHD drugs.

Prevention 62

Prevention Population Health Accountability Life Sciences 62

Healthcare Success

NOVEMBER 25, 2024

And on the client side, most of not all, but most of the people that we work with are in the life sciences. Some of the bigger getting bigger and seems to be the place where, at least from the life sciences, perspective, where they have the most questions, and where there's a lot of change happening. So those are 2 areas.

Integration 157

Integration Healthcare Doctors Life Sciences 157

Health Populi

OCTOBER 8, 2019

Thus, administrative complexity, which includes billing and coding waste, and physician time spent reporting on quality measures, accounted for the largest component of waste in American health care. Pricing failure as a waste-factor accounted for nearly another third of total waste in U.S. medical spending. health care.

Pharmaceuticals 108

Pharmaceuticals Medicare Life Sciences Accountability 108

HIT Consultant

JUNE 29, 2022

The Covid-19 pandemic has led to a surge in innovation across the life sciences industry, including vaccines and treatments being developed, approved, manufactured and delivered at an unprecedented scale in a matter of months – truly a remarkable achievement, and a testament to human ingenuity. About Annette Williams.

Regulations 98

Regulations Life Sciences Pharmaceuticals Accountability 98

Healthcare ECONOMIST

SEPTEMBER 20, 2021

To account for rebates in the US they use SSR Health information Then international prices are identified based on the IQVIA MIDAS data across 6 markets (Australia, Canada, France, Germany, Japan, and the U.K). The authors use IQVIA MIDAS data to estimate sales price and volume in the US. Title II of H.R. There is no free lunch.

Pharmaceuticals 114

Pharmaceuticals Life Sciences Accountability 114

HIT Consultant

APRIL 7, 2023

Additionally, digitized health records have been used to make patient information more easily accessible, first to meet Health Insurance Portability and Accountability Act (HIPAA) and HITECH mandates, and now, increasingly, to meet the 21st Century Cures Act ‘Final Rule’ mandate, requiring timely and standardized access to all patient data.

Hospitals 52

Hospitals Life Sciences Accountability Integration 52

Health Populi

JUNE 18, 2020

Kesselheim, are affiliated with the London School of Economics and Brigham and Women’s Hospital in Boston, note that 1% of medicines dispensed under Medicare Part D and Medicaid accounted for nearly $1 in $3 of drug spending in each program in 2015. bn to $32.8 bn between 2019 and 2015 (Part D) and from $4.8 bn to $9.9

Medicaid 79

Medicaid Medicare Accountability Prevention 79